newswire

Hillstream BioPharma Announces Abstract at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting Highlighting HSB-1216’s Effect in Triple Negative Breast ...

BRIDGEWATER, NJ, June 2, 2021 (Newswire.com) - HSB-1216 and a Novel Anthracycline, Pirarubicin, Combined and Targeted Using Quatramer Shows Synergistic Effect in TNBC Hillstream BioPharma, Inc.
newswire

Hillstream BioPharma Adds Leading Cancer Drug Development Executive and Features Hillstream's Quatramer-Based Ferroptosis Inducer, HSB-1216, in Two Abstracts Available for ...

BRIDGEWATER, NJ, March 11, 2021 (Newswire.com) - Lynne A. Bui M.D., leading cancer drug development executive, joins Hillstream BioPharma's Board of Directors Abstracts highlight mechanistic and ...